![Bernd Winterhalter](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bernd Winterhalter
Corporate Officer/Principal presso CureVac SE
Posizioni attive di Bernd Winterhalter
Società | Posizione | Inizio | Fine |
---|---|---|---|
CureVac SE
![]() CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Corporate Officer/Principal | 01/12/2019 | - |
Storia della carriera di Bernd Winterhalter
Precedenti posizioni note di Bernd Winterhalter
Società | Posizione | Inizio | Fine |
---|---|---|---|
CUREVAC N.V. | Corporate Officer/Principal | 01/12/2019 | 01/02/2021 |
Bristol-Myers Squibb GmbH & Co. KGaA
![]() Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb GmbH & Co. KGaA is a German company that manufactures biopharmaceutical medicines. The company is based in Munich, Germany. The CEO of the company is Han Steutel. | Direttore Tecnico/Scientifico/R&S | 01/01/2004 | 01/01/2018 |
Pharmacia GmbH | Direttore Tecnico/Scientifico/R&S | 01/01/1997 | 01/01/2003 |
Formazione di Bernd Winterhalter
University of Freiburg | Doctorate Degree |
Statistiche
Distribuzione geografica
Germania | 6 |
Posizioni
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Settori
Health Technology | 4 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
CUREVAC N.V. | Health Technology |
Aziende private | 3 |
---|---|
CureVac SE
![]() CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
Bristol-Myers Squibb GmbH & Co. KGaA
![]() Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb GmbH & Co. KGaA is a German company that manufactures biopharmaceutical medicines. The company is based in Munich, Germany. The CEO of the company is Han Steutel. | Health Technology |
Pharmacia GmbH |
- Borsa valori
- Insiders
- Bernd Winterhalter
- Esperienza